Financial News
Latest News about KYMR
Recent news which mentions KYMR
63 Biggest Movers From Thursday
January 04, 2021
From Benzinga
62 Biggest Movers From Yesterday
December 30, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
December 29, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 28, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 24, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 22, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 18, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
From Benzinga
The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations
December 10, 2020
From Benzinga
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
December 09, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 4, 2020
December 04, 2020
From Benzinga
The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut
December 03, 2020
From Benzinga
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway
November 19, 2020
From Benzinga
The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted
November 18, 2020
From Benzinga
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
November 12, 2020
From Benzinga
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
12 Healthcare Stocks Moving In Friday's Intraday Session
October 23, 2020
From Benzinga
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
October 20, 2020
From Benzinga
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
October 15, 2020
From Benzinga
The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts
October 14, 2020
From Benzinga
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For September 15, 2020
September 15, 2020
From Benzinga
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
September 13, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial
September 10, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
